LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Y39983 | 10 | uM | LJP6 | 2 | P01 | 72 | hr | 1311 | 804 | 4961 | 0.1620 | -0.2251 |
MDA-MB-231 | Y39983 | 10 | uM | LJP6 | 3 | P01 | 72 | hr | 1311 | 684 | 4973 | 0.1375 | -0.2873 |
MDA-MB-231 | Nintedanib | 0.04 | uM | LJP6 | 1 | H06 | 72 | hr | 1311 | 5171 | 4870 | 1.0618 | 1.0643 |
MDA-MB-231 | Nintedanib | 0.04 | uM | LJP6 | 2 | H06 | 72 | hr | 1311 | 4970 | 4961 | 1.0017 | 1.0018 |
MDA-MB-231 | Nintedanib | 0.04 | uM | LJP6 | 3 | H06 | 72 | hr | 1311 | 5395 | 4973 | 1.0847 | 1.0864 |
MDA-MB-231 | Nintedanib | 0.12 | uM | LJP6 | 1 | H05 | 72 | hr | 1311 | 5119 | 4870 | 1.0511 | 1.0533 |
MDA-MB-231 | Nintedanib | 0.12 | uM | LJP6 | 2 | H05 | 72 | hr | 1311 | 5162 | 4961 | 1.0404 | 1.0417 |
MDA-MB-231 | Nintedanib | 0.12 | uM | LJP6 | 3 | H05 | 72 | hr | 1311 | 5114 | 4973 | 1.0282 | 1.0291 |
MDA-MB-231 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 1311 | 5030 | 4870 | 1.0328 | 1.0344 |
MDA-MB-231 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 1311 | 4763 | 4961 | 0.9600 | 0.9579 |
MDA-MB-231 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 1311 | 4858 | 4973 | 0.9767 | 0.9757 |
MDA-MB-231 | Nintedanib | 1.11 | uM | LJP6 | 1 | H03 | 72 | hr | 1311 | 4686 | 4870 | 0.9622 | 0.9597 |
MDA-MB-231 | Nintedanib | 1.11 | uM | LJP6 | 2 | H03 | 72 | hr | 1311 | 4729 | 4961 | 0.9531 | 0.9506 |
MDA-MB-231 | Nintedanib | 1.11 | uM | LJP6 | 3 | H03 | 72 | hr | 1311 | 4900 | 4973 | 0.9852 | 0.9845 |
MDA-MB-231 | Nintedanib | 3.33 | uM | LJP6 | 1 | H02 | 72 | hr | 1311 | 4450 | 4870 | 0.9137 | 0.9069 |
MDA-MB-231 | Nintedanib | 3.33 | uM | LJP6 | 2 | H02 | 72 | hr | 1311 | 4649 | 4961 | 0.9370 | 0.9333 |
MDA-MB-231 | Nintedanib | 3.33 | uM | LJP6 | 3 | H02 | 72 | hr | 1311 | 4756 | 4973 | 0.9562 | 0.9540 |
MDA-MB-231 | Nintedanib | 10 | uM | LJP6 | 1 | H01 | 72 | hr | 1311 | 3811 | 4870 | 0.7825 | 0.7569 |
MDA-MB-231 | Nintedanib | 10 | uM | LJP6 | 2 | H01 | 72 | hr | 1311 | 4191 | 4961 | 0.8447 | 0.8316 |
MDA-MB-231 | Nintedanib | 10 | uM | LJP6 | 3 | H01 | 72 | hr | 1311 | 4890 | 4973 | 0.9832 | 0.9824 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 1 | H12 | 72 | hr | 1311 | 4636 | 5128 | 0.9040 | 0.9000 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 2 | H12 | 72 | hr | 1311 | 4446 | 5100 | 0.8718 | 0.8647 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 3 | H12 | 72 | hr | 1311 | 4339 | 5010 | 0.8659 | 0.8565 |
MDA-MB-231 | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 1311 | 3336 | 5128 | 0.6505 | 0.6073 |
MDA-MB-231 | Foretinib | 0.12 | uM | LJP5 | 2 | H11 | 72 | hr | 1311 | 3416 | 5100 | 0.6698 | 0.6300 |